CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) was the recipient of a significant growth in short interest in the month of July. As of July 15th, there was short interest totaling 32,429 shares, a growth of 79.0% from the June 30th total of 18,115 shares. Based on an average daily trading volume, of 93,408 shares, the short-interest ratio is currently 0.3 days. Approximately 0.0% of the shares of the company are sold short.
Analysts Set New Price Targets
CHEOY has been the subject of several analyst reports. Royal Bank Of Canada downgraded shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price target for the company. in a report on Thursday, July 16th. Jefferies Financial Group downgraded shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, July 22nd. Zacks Research raised shares of CochLear from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. Finally, UBS Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Thursday, April 23rd. One equities research analyst has rated the stock with a Strong Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, CochLear has a consensus rating of “Hold” and a consensus price target of $117.00.
View Our Latest Research Report on CHEOY
CochLear Stock Performance
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
See Also
- Five stocks we like better than CochLear
- L3Harris’ Record Backlog Makes Its Stock Sell-Off Look Overdone
- Quantum Earnings Could Decide Whether the Sector’s Sell-Off Has Gone Too Far
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
